Investment analysts at National Bank Financial lifted their FY2024 earnings estimates for shares of EMX Royalty in a note issued to investors on Monday, February 10th. National Bank Financial analyst ...

Analysts at National Bank Financial issued their Q4 2024 earnings per share (EPS) estimates for shares of Metalla Royalty & ...

Is Royalty Pharma a buy or sell going into earnings? Read our full analysis here, it’s free. This quarter, analysts are expecting Royalty Pharma’s revenue to grow 1.6% year on year to $605.4 ...

Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) in Q4 CY2024, with sales flat year on year at $594 million. Its ...

Healthcare royalties company Royalty Pharma (NASDAQ:RPRX) will be reporting earnings tomorrow morning. Here’s what to look ...

Coming-of-age films will never go out of style. Whether they’re realistic or fantastical or a combination of genres, they ...

Alkermes PLC (ALKS) reports over $1.5 billion in revenue, retires all debt, and outlines strategic plans for 2025 amidst ...

A bipartisan group of US House members has reintroduced the Local Radio Freedom Act, a resolution opposing new performance ...

Arm Holdings plc's strong growth in AI computing and partnerships still face valuation risks. Click for my post-earnings ...

Biogen Inc. CEO Christopher Viehbacher gave investors an overview of what type of deals the company is looking for Wednesday ...

PepsiCo has treated its investors like royalty over the years. Chevron continues to deliver above-average dividend growth.

The resources minister wants to see royalties redirected to the regions as the debate over coal’s economic benefits intensifies ...